Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Drawing the dose accurately Pull the plunger back past your target unit marking, then slowly push it forward to the exact number
Gastrointestinal side effects are by far the most prevalent during early treatment: Nausea Very common (may affect more than 1 in 10 people), typically peaking during the first week and often improving over two to four weeks [1] [2] Vomiting Common (may affect up to 1 in 10 people), usually occurring alongside nausea [1] [2] Diarrhoea Common, may persist for several weeks Constipation Common, sometimes alternating with diarrhoea Abdominal pain or discomfort Common, ranging from mild cramping to more pronounced discomfort Dyspepsia (indigestion) Common Eructation (belching) Common Reduced appetite A therapeutic effect that may feel uncomfortable initially, affecting eating patterns These symptoms arise because semaglutide mimics the natural GLP-1 hormone, which slows gastric emptying and increases satiety
Your provider will determine the most appropriate strategy based on your labs and health history
4 Rates were lower in TRANSCEND-T2D-1: 5.1% at 12 mg, 4.5% at 9 mg, and 2.2% at 4 mg
Oxidative phosphorylation and ATP production are impaired and energy demanding organs most often show symptoms
Store it in a dry place below 30C
